{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:31:28Z","timestamp":1787758288927,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Inflammatory markers are among the possible contributing factors with a proposed role in hepatic and ischemic heart disease. The present study aimed to determine the association between high-sensitivity-C-reactive protein (hs-CRP), liver elastography, and cardiac ischemic diseases in patients with fatty liver.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this cross-sectional comparative study, 103 consecutive patients with fatty liver were enrolled to undergo angiography. They were divided into groups with and without cardiac ischemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results demonstrated that the mean hs-CRP was 2.3 and 10.9 mg\/L in normal and ischemic angiography groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). According to the receiver operating characteristic (ROC) analysis, the predictive role for hs-CRP was 94.5% that had sensitivity and specificity of 95.2% and 90%, respectively, with a cut-off point of 3.1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study showed that there is an association between the fatty liver, cardiac ischemia, and hs-CRP level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2223_21","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T07:34:07Z","timestamp":1666164847000},"page":"5495-5499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association between high-sensitivity-CRP and liver elastography and cardiac ischemic diseases in patients with fatty liver"],"prefix":"10.4103","volume":"11","author":[{"given":"Morteza","family":"Nayebi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed","family":"Seyedian","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Jalal","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abazar","family":"Parsi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskandar","family":"Hajiani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Toshikuni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease:Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content:Prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J PhysiolEndocrinol Metabol"},{"key":"B4-20240828","first-page":"511","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"ClinLiver Dis"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma:Aweighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography:Anew noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound MedBiol"},{"key":"B7-20240828","first-page":"1214","article-title":"Ultrasound-based transient elastography for the detection of hepatic fibrosis:Systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"ClinGastroenterolHepatol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"B9-20240828","article-title":"Global Atlas on Cardiovascular Disease Prevention and Control","author":"Mendis","year":"2011","journal-title":"World Health Organization"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.302.21.2388","article-title":"Coronary heart disease risk factors","volume":"302","author":"Torpy","year":"2009","journal-title":"JAMA"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ehj.2014.11.005","article-title":"C-reactive protein, inflammation and coronary heart disease","volume":"67","author":"Shrivastava","year":"2015","journal-title":"Egypt Heart J"},{"key":"B12-20240828","first-page":"261","article-title":"C-reactive protein","volume":"30","author":"Du","year":"2004","journal-title":"ImmunolRes"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/QAD.0000000000000654","article-title":"Association of HIV, HCV and liver fibrosis severity with IL-6 and CRP levels","volume":"29","author":"Shah","year":"2015","journal-title":"AIDS"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj3270425","article-title":"Interleukin-6-dependent and-independent regulation of the human C-reactive protein gene","volume":"327","author":"Weinhold","year":"1997","journal-title":"Biochem J"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2796.2008.02015.x","article-title":"C-reactive protein and coronary heart disease:Acritical review","volume":"264","author":"Casas","year":"2008","journal-title":"JIntern Med"},{"key":"B16-20240828","first-page":"125","article-title":"A study of C-reactive protein and its relationship with CHD and lipid metabolism","volume":"6","author":"Devaki","year":"2011","journal-title":"Int J Pharm Sci RevRes"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"e0172666","DOI":"10.1371\/journal.pone.0172666","article-title":"High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"B18-20240828","first-page":"28","article-title":"Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver","volume":"5","author":"Foroughi","year":"2016","journal-title":"AdvBiomed Res"},{"key":"B19-20240828","first-page":"422","article-title":"High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease","volume":"61","author":"Yeniova","year":"2014","journal-title":"Hepatogastroenterol"},{"key":"B20-20240828","first-page":"1399","article-title":"The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population","volume":"43","author":"Chiang","year":"2010","journal-title":"ClinBiochem"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2concentrations:Aplacebo-controlled study using a highly sensitive C-reactive protein assay","volume":"37","author":"Feldman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cyto.2014.01.003","article-title":"Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention:Apopulation-based study (CoLaus Study)","volume":"66","author":"Vaucher","year":"2014","journal-title":"Cytokine"},{"key":"B23-20240828","first-page":"1","article-title":"Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet. es study","volume":"43","author":"Rojo-Mart\u00ednez","year":"2013","journal-title":"EurJClin Invest"},{"key":"B24-20240828","first-page":"619","article-title":"High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis","volume":"24","author":"Mortensen","year":"2012","journal-title":"EurJGastroenterology Hepatol"},{"key":"B25-20240828","first-page":"147","article-title":"Non-alcoholic fatty liver disease:An update on diagnosis","volume":"91","author":"Dumitrascu","year":"2018","journal-title":"Clujul Med"},{"key":"B26-20240828","first-page":"23","article-title":"Inflammatory markers in coronary heart disease","volume":"100","author":"Madjid","year":"2011","journal-title":"BrMed Bull"},{"key":"B27-20240828","first-page":"173","article-title":"Value of CRP in coronary risk determination","volume":"59","author":"Mehta","year":"2007","journal-title":"Indian Heart J"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein:Acritical update","volume":"111","author":"Pepys","year":"2003","journal-title":"JClin Invest"},{"key":"B29-20240828","first-page":"948","article-title":"Nonalcoholic fatty liver disease and the heart:JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"JAmCollCardiol"},{"key":"B30-20240828","first-page":"298","article-title":"Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease","volume":"27","author":"Dogan","year":"2015","journal-title":"EurJGastroenterolHepatol"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk:Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"JHepatol"},{"key":"B32-20240828","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction:Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2223_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:12:30Z","timestamp":1787757150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2223_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2223_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"2021-11-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}